Perkins Adelene Q 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Jun 14, 2019
Insider Transaction Report
Form 4
Perkins Adelene Q
Pres & Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2019-06-13+242,000→ 242,000 totalExercise: $1.24Exp: 2029-01-03→ Common Stock (242,000 underlying)
Footnotes (2)
- [F1]This option was approved by the Compensation Committee of the Board of Directors of Infinity Pharmaceuticals, Inc., on January 4, 2019, contingent upon shareholder approval of the Company's 2019 Equity Incentive Plan under which the options were granted, which was approved by shareholders on June 13, 2019.
- [F2]The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter.